Quarterly Report I 12/13

Quarterly Report 1, Diamyd Medical AB (publ), fiscal year 2012/2013 (www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker: DMYDY)Reporting period September 1, 2012 – November 30, 2012 · Group net sales amounted to MSEK 0 (0.2) · Loss before tax amounted to MSEK -1.8 (-3.5) · Earnings per share after dilution were SEK -0.2 (-0.3) · Liquid assets and short term investments amounted to MSEK 373 (414) as of November 30, 2012 Significant events during the reporting period · Agreement was entered into for the sale of US gene therapy company and an Extraordinary General